Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

Cellero Antigen-Specific T Cells Propel Breast Cancer Research

Antigen-Specific T Cells in Breast Cancer An independent publication from a cancer research group at Indiana University cites using Cellero antigen-specific T cell products to examine mechanisms of immune evasion.[1] Immune surveillance is the human body’s strongest defense against invasive cancer cells. The uncanny ability to evade that surveillance and grow aggressively is exactly what…

Ask A Scientist:What’s the Difference Between Human Monocytes and Macrophages?

Monocytes and macrophages are very closely related cells with a few important distinctions and different use cases. Put simply, monocytes are macrophages in the blood; macrophages are monocytes in tissue.   Understanding the Difference Monocytes are the largest type of white blood cells and play an important role in the adaptive immunity process. Monocytes typically…

The Ideal Starting Material for Celiac Disease Research: Celiac PBMC

Today we are announcing the latest in our line-up of disease-state PBMC products: Celiac Disease PBMC! Celiac Disease has become increasingly prevalent over the past decade, both in medical diagnosis and global awareness. An estimated 3 million Americans have Celiac Disease, although 80% are undiagnosed. The best “treatment” for people who have Celiac Disease or…